Industry Focus

Earlier this month, FedEx announced that it would no longer provide domestic express service to Amazon. What does this breakup mean for Amazon, e-commerce, and the future of logistics? Motley Fool Contributor Dan Kline joins the show to answer this question and more on this week’s episode of Industry Focus: Energy & Industrials.

Stocks Mentioned: FDX, AMZN, UPS, SHOP, WMT, TGT, DG

 

Check out more of our content here:

 

StockUp, The Motley Fool's weekly email newsletter

 

Podcasts

 

Youtube

 

Twitter

 

Reach us by Email @ [email protected]

 

Thanks to Sprout Social for supporting The Motley Fool. To learn how your brand can create real connection, visit sproutsocial.com/fool today.

Most investors will never come in contact with the products that are made by medical device companies. That fact can make it hard for them to research these types of businesses. However, when a medical device company creates a game-changing product it can often go on to create huge shareholder value in time. On this week's episode of Industry Focus: Healthcare, host Shannon Jones sits down with Fool.com's Brian Feroldi to talk about three hidden medical device makers that could be on the verge of generating meaningful returns for their investors: ViewRay, Nervo, and LeMaitre Vascular.

Stocks: VRAY, NVRO, LMAT

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

America’s malls are changing. Some well-known retail brands have gone away replaced by digital retailers. That has forced mall operators to be creative in finding alternative ways to fill space. That’s a work in progress at many malls but it’s something the owners of at least some malls have proven successful at doing.

Thanks to Sprout Social for supporting Motley Fool. To learn how your brand can create real connection, visit sproutsocial.com/fool today.

 

 

On this week’s episode of Industry Focus: Financials host Jason Moser sits down with Brendan Mathews, VP of Motley Fool Ventures to talk about working in venture capital, the types of companies they're looking at, the differences between public and private investing and some of the big trends the team is following!

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

Another tech unicorn is going public -- Slack! We break down how the SaaS communication company works, its financials and its $17B valuation. We also explain the company's curious name, and why it has an eerie resemblance to Fool favorite Shopify.

Stocks: WORK, SHOP

It’s been a wild couple weeks for Fiat Chrysler and Renault. After Fiat made a merger offer in late May, Renault shareholders Nissan and the French government balked at the deal, leading Fiat to withdraw its offer. Motley Fool Senior Auto Analyst John Rosevear joins the podcast to break down the political issues that have sidetracked the merger and discuss why we’ve been seeing so many major automotive partnerships recently, both between OEMs and autonomy startups.

Stocks Mentioned: FCAU, RNLSY, NSANY, GM, F, VWAGY, RACE, TSLA, HMC, TM

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

$50 off your first job post. Linkedin.com/fool  

It’s been a wild couple weeks for Fiat Chrysler and Renault. After Fiat made a merger offer in late May, Renault shareholders Nissan and the French government balked at the deal, leading Fiat to withdraw its offer. Motley Fool Senior Auto Analyst John Rosevear joins the podcast to break down the political issues that have sidetracked the merger and discuss why we’ve been seeing so many major automotive partnerships recently, both between OEMs and autonomy startups.

Stocks Mentioned: FCAU, RNLSY, NSANY, GM, F, VWAGY, RACE, TSLA, HMC, TM

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

$50 off your first job post. Linkedin.com/fool  

Earlier this month, industry watchers gathered at the annual American Society of Clinical Oncology (ASCO) conference to discuss the latest research in the battle against cancer. In today's show, biotech investing expert Brad Loncar shares his key takeaways from the event, including must-hear insight into programs underway at Iovance Biotherapeutics, MacroGenics, and the biotech unicorn, Grail.

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

Earlier this month, industry watchers gathered at the annual American Society of Clinical Oncology (ASCO) conference to discuss the latest research in the battle against cancer. In today's show, biotech investing expert Brad Loncar shares his key takeaways from the event, including must-hear insight into programs underway at Iovance Biotherapeutics, MacroGenics, and the biotech unicorn, Grail.

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

We’re re-airing one of our favorite episodes from last year -- we breakdown how scams works, the signs of a scam, and how you can protect yourself with Fool.com's resident detective, Matthew Cochrane.

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter